Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-Dose Cytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis

Ferreri, Andres JM ; Reni, Michele ; Foppoli, Marco ; Martelli, Maurizio ; Siakantaris, Marina ; Frezzato, Maurizio ; Cabras, Maria Giuseppina ; Fabbri, Alberto ; Corazzelli, Gaetano ; Ilariucci, Fiorella ; Rossi, Giuseppe ; Soffietti, Riccardo ; Stelitano, Caterina ; Vallisa, Daniele ; Zaja, Francesco ; Gelemur, Marta ; Aondio, Gian Marco ; Avvisati, Giuseppe ; Balzarotti, Monica ; Brandes, Alba ; Costa, Maria Joao ; Gomez, Henry ; Guarini, Attilio ; Pinotti, Graziella ; Rigacci, Luigi ; Uhlmann, Catrina ; Angelopoulou, Maria ; Tirindelli, Maria ; Naso, Virginia ; Franzin, Alberto ; Anzalone, Nicoletta ; Ponzoni, Maurilio ; Zucca, Emanuele ; Cappio, Federico Caligaris ; Cavalli, Franco

Blood, 2008-11, Vol.112 (11), p.580-580 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível